Matthew A. Tyler

1.8k total citations
29 papers, 1.0k citations indexed

About

Matthew A. Tyler is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Matthew A. Tyler has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 15 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Matthew A. Tyler's work include Virus-based gene therapy research (16 papers), CAR-T cell therapy research (13 papers) and RNA Interference and Gene Delivery (13 papers). Matthew A. Tyler is often cited by papers focused on Virus-based gene therapy research (16 papers), CAR-T cell therapy research (13 papers) and RNA Interference and Gene Delivery (13 papers). Matthew A. Tyler collaborates with scholars based in United States, Germany and Israel. Matthew A. Tyler's co-authors include Ilya V. Ulasov, Maciej S. Lesniak, Adam M. Sonabend, Yu Han, Ángel A. Rivera, Amber Luong, J. Michael Mathis, Zeng B. Zhu, Atique U. Ahmed and Maciej S. Lesniak and has published in prestigious journals such as Cancer Research, Stem Cells and Molecular Therapy.

In The Last Decade

Matthew A. Tyler

26 papers receiving 1.0k citations

Peers

Matthew A. Tyler

GENET

ONCOL

GENET

BIOTE

Stephanie Laufs Germany

Christopher J. Lees United States

Katja Storch Germany

Alena Cristina Jaime‐Ramirez United States

Heechung Kwon South Korea

Danuta Balicki United States

Caleb M. Bailey United States

Tanja Hakkarainen Finland

Lisa J. Harper United Kingdom

Zongliang Zhang China

Stephanie Laufs Germany

Matthew A. Tyler

824 ×1.3

574 ×1.1

GENET

394 ×0.9

ONCOL

120 ×0.6

GENET

41 ×0.4

BIOTE

Citations per year, relative to Matthew A. Tyler Matthew A. Tyler (= 1×) peers Stephanie Laufs

Countries citing papers authored by Matthew A. Tyler

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Tyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Tyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Tyler more than expected).

Fields of papers citing papers by Matthew A. Tyler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Tyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Tyler. The network helps show where Matthew A. Tyler may publish in the future.

Co-authorship network of co-authors of Matthew A. Tyler

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Tyler. A scholar is included among the top collaborators of Matthew A. Tyler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Tyler. Matthew A. Tyler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fletcher, Joshua R., Amanda Hanna, C. Daniel Freeman, et al.. (2025). Commensal-derived short-chain fatty acids disrupt lipid membrane homeostasis in Staphylococcus aureus. mBio. 17(1). e0139225–e0139225.

Ganti, Ashwin, et al.. (2024). Characterizing Trends in Diagnosis and Management of Sinusitis in a Large Health Care System: From Primary Care to Otolaryngology. Annals of Otology Rhinology & Laryngology. 133(5). 476–484.

Dhawan, Sanjay, et al.. (2023). Prognostic Factors and Treatment Impact on Overall Survival in Adult Craniopharyngioma. World Neurosurgery. 173. e132–e139. 6 indexed citations

Hwang, Peter H., et al.. (2023). Chronic Rhinosinusitis After Maxillary Advancement Orthognathic Surgery. Annals of Otology Rhinology & Laryngology. 133(3). 261–267.

Contrera, Kevin J., Mark Zafereo, Dan Yaniv, et al.. (2022). Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncology. 134. 106127–106127. 13 indexed citations

Araki, Takako, Daniel Guillaume, Ramachandra P. Tummala, et al.. (2021). Estimating Risk of Pituitary Apoplexy after Resection of Giant Pituitary Adenomas. Journal of Neurological Surgery Part B Skull Base. 83(S 02). e152–e159. 6 indexed citations

Tyler, Matthew A. & Amber Luong. (2020). Current Concepts in the Management of Allergic Fungal Rhinosinusitis. Immunology and Allergy Clinics of North America. 40(2). 345–359. 15 indexed citations

Tyler, Matthew A., et al.. (2020). Endoscopic Endonasal Approach for Resection of Suprasellar Hemangioblastoma: Selective Pituitary Sacrifice and Use of Indocyanine Dye: 2-Dimensional Operative Video. Operative Neurosurgery. 20(1). E46–E47. 3 indexed citations

Tyler, Matthew A. & Amber Luong. (2018). Current understanding of allergic fungal rhinosinusitis. World Journal of Otorhinolaryngology - Head and Neck Surgery. 4(3). 179–185. 40 indexed citations

10.

Ahmed, Atique U., Cleo E. Rolle, Matthew A. Tyler, et al.. (2010). Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model. Molecular Therapy. 18(10). 1846–1856. 58 indexed citations

11.

Dey, Mahua, Ilya V. Ulasov, Matthew A. Tyler, Adam M. Sonabend, & Maciej S. Lesniak. (2010). Cancer Stem Cells: The Final Frontier for Glioma Virotherapy. Stem Cell Reviews and Reports. 7(1). 119–129. 38 indexed citations

12.

Tyler, Matthew A., Ilya V. Ulasov, & Maciej S. Lesniak. (2009). Cancer cell death by design: Apoptosis, autophagy and glioma virotherapy. Autophagy. 5(6). 856–857. 15 indexed citations

13.

Tyler, Matthew A., et al.. (2009). Stem Cells as Delivery Vehicles for Oncolytic Adenoviral Virotherapy. Current Gene Therapy. 9(5). 389–395. 15 indexed citations

14.

Ulasov, Ilya V., et al.. (2008). Evaluation of E1A double mutant oncolytic adenovectors in anti‐glioma gene therapy. Journal of Medical Virology. 80(9). 1595–1603. 16 indexed citations

15.

Tyler, Matthew A., Adam M. Sonabend, Ilya V. Ulasov, & Maciej S. Lesniak. (2008). Vector therapies for malignant glioma: shifting the clinical paradigm. Expert Opinion on Drug Delivery. 5(4). 445–458. 4 indexed citations

16.

Tyler, Matthew A., Ilya V. Ulasov, Adam M. Sonabend, et al.. (2008). Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Therapy. 16(2). 262–278. 97 indexed citations

17.

Sonabend, Adam M., Ilya V. Ulasov, Yu Han, et al.. (2008). Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats. Cancer Gene Therapy. 16(4). 362–372. 26 indexed citations

18.

Ulasov, Ilya V., et al.. (2007). Fiber‐knob modifications enhance adenoviral tropism and gene transfer in malignant glioma. The Journal of Gene Medicine. 9(3). 151–160. 38 indexed citations

19.

Ulasov, Ilya V., Matthew A. Tyler, Yu Han, Joel N. Glasgow, & Maciej S. Lesniak. (2007). Novel Recombinant Adenoviral Vector That Targets The Interleukin-13 Receptor α2 Chain Permits Effective Gene Transfer to Malignant Glioma. Human Gene Therapy. 18(2). 118–129. 24 indexed citations

20.

Ulasov, Ilya V., et al.. (2006). CD46 Represents a Target for Adenoviral Gene Therapy of Malignant Glioma. Human Gene Therapy. 17(5). 556–564. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact